166 related articles for article (PubMed ID: 38336722)
1. Factors associated with gaps in naloxone knowledge: evidence from a 2022 great plains survey.
Cooper-Ohm S; Habecker P; Humeniuk R; Bevins RA
Harm Reduct J; 2024 Feb; 21(1):37. PubMed ID: 38336722
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated with Gaps in Naloxone Knowledge: Evidence from a 2022 Great Plains Survey.
Cooper-Ohm S; Habecker P; Humeniuk R; Bevins RA
Res Sq; 2023 Nov; ():. PubMed ID: 37961638
[TBL] [Abstract][Full Text] [Related]
3. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
[TBL] [Abstract][Full Text] [Related]
4. Harm reduction in the Heartland: public knowledge and beliefs about naloxone in Nebraska, USA.
Schlosser A; Habecker P; Bevins R
Harm Reduct J; 2022 Mar; 19(1):22. PubMed ID: 35246153
[TBL] [Abstract][Full Text] [Related]
5. If we build it, will they come? Perspectives on pharmacy-based naloxone among family and friends of people who use opioids: a mixed methods study.
Slocum S; Ozga JE; Joyce R; Walley AY; Pollini RA
BMC Public Health; 2022 Apr; 22(1):735. PubMed ID: 35418048
[TBL] [Abstract][Full Text] [Related]
6. Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City.
Bennett AS; Scheidell J; Bowles JM; Khan M; Roth A; Hoff L; Marini C; Elliott L
Harm Reduct J; 2022 Mar; 19(1):20. PubMed ID: 35246165
[TBL] [Abstract][Full Text] [Related]
7. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J;
Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808
[TBL] [Abstract][Full Text] [Related]
8. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.
Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC
Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372
[TBL] [Abstract][Full Text] [Related]
9. Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?
Adeosun SO
J Pharm Pract; 2023 Aug; 36(4):941-952. PubMed ID: 35505618
[TBL] [Abstract][Full Text] [Related]
10. Opportunities to boost naloxone awareness among people who misuse opioid analgesics who have not used illegal opioids.
Gicquelais RE; Bohnert ASB; Fernandez AC
Subst Abus; 2021; 42(3):372-376. PubMed ID: 32692621
[TBL] [Abstract][Full Text] [Related]
11. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
[TBL] [Abstract][Full Text] [Related]
12. Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.
Abdelal R; Raja Banerjee A; Carlberg-Racich S; Darwaza N; Ito D; Shoaff J; Epstein J
Harm Reduct J; 2022 May; 19(1):49. PubMed ID: 35596213
[TBL] [Abstract][Full Text] [Related]
13. "They're not doing enough.": women's experiences with opioids and naloxone in Toronto.
Macleod ER; Tajbakhsh I; Hamilton-Wright S; Laliberte N; Wiese JL; Matheson FI
Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):26. PubMed ID: 33743756
[TBL] [Abstract][Full Text] [Related]
14. "That's why we're speaking up today": exploring barriers to overdose fatality prevention in Indianapolis' Black community with semi-structured interviews.
Seo DC; Satterfield N; Alba-Lopez L; Lee SH; Crabtree C; Cochran N
Harm Reduct J; 2023 Oct; 20(1):159. PubMed ID: 37891632
[TBL] [Abstract][Full Text] [Related]
15. A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City.
Parkin S; Neale J; Brown C; Jones JD; Brandt L; Castillo F; Campbell ANC; Strang J; Comer SD
Int J Drug Policy; 2021 Jan; 87():102968. PubMed ID: 33096365
[TBL] [Abstract][Full Text] [Related]
16. Addiction stigma and the production of impediments to take-home naloxone uptake.
Fomiatti R; Farrugia A; Fraser S; Dwyer R; Neale J; Strang J
Health (London); 2022 Mar; 26(2):139-161. PubMed ID: 32529843
[TBL] [Abstract][Full Text] [Related]
17. Naloxone Knowledge and Attitudes Towards Overdose Response Among Family Members of People who Misuse Opioids.
Resko SM; Pasman E; Hicks DL; Lee G; Ellis JD; O'Shay S; Brown S; Agius E
J Community Health; 2024 Feb; 49(1):70-77. PubMed ID: 37450091
[TBL] [Abstract][Full Text] [Related]
18. Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.
Donovan E; Case P; Bratberg JP; Baird J; Burstein D; Walley AY; Green TC
J Urban Health; 2019 Jun; 96(3):367-378. PubMed ID: 30747371
[TBL] [Abstract][Full Text] [Related]
19. Do naloxone access laws affect perceived risk of heroin use? Evidence from national US data.
Kelly BC; Vuolo M
Addiction; 2022 Mar; 117(3):666-676. PubMed ID: 34617356
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of opioid overdose prevention and response training on medical student knowledge and attitudes toward opioid overdose: A pilot study.
Moses TEH; Chou JS; Moreno JL; Lundahl LH; Waineo E; Greenwald MK
Addict Behav; 2022 Mar; 126():107172. PubMed ID: 34774365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
